Endocrine Outcomes After Pituitary Surgery.
Adrenal insufficiency
Growth hormone
Hypogonadism
Pituitary surgery
Prolactin
Journal
Neurosurgery clinics of North America
ISSN: 1558-1349
Titre abrégé: Neurosurg Clin N Am
Pays: United States
ID NLM: 9008004
Informations de publication
Date de publication:
Oct 2019
Oct 2019
Historique:
entrez:
1
9
2019
pubmed:
1
9
2019
medline:
23
2
2020
Statut:
ppublish
Résumé
Although removal of pituitary tumors yields excellent surgical outcomes, perturbations in the hypothalamic-pituitary axis are not uncommon. Careful assessment of postoperative hormone status with supplementation or further medical therapy is critical to successful outcomes. Although many centers routinely use perioperative steroids, they can be associated with worse outcomes in the absence of intact preoperative adrenal function or damage to the pituitary gland or stalk during surgery. Postoperative assessment of prolactin, cortisol, and growth hormone can be prognostic of surgical cure. Hormonal axes should be reevaluated routinely several weeks after surgery, because longitudinal monitoring is important for surgical and medical outcomes.
Identifiants
pubmed: 31471056
pii: S1042-3680(19)30045-2
doi: 10.1016/j.nec.2019.05.009
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
491-498Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.